1. Home
  2. News, Deals & Insights
  3. Deal Announcements

DC Advisory advised Sinfonia HealthCare Corp on its sale to Tabula Rasa HealthCare

Sifonia

DC Advisory* is pleased to announce that its client SinfoníaRx (https://sinfoniarx.com/), the industry leader in Medication Therapy Management (MTM) technology and services for Medicare, Medicaid and Commercial Health plans, has been acquired by Tabula Rasa HealthCare (NASDAQ:TRHC).

SinfoníaRx is a rapidly growing healthcare company offering innovative solutions for health entities, patients and caregivers. SinfoníaRx works directly with patients, their providers, and community pharmacists to ensure optimal treatment while reducing the risk of adverse events and drug interactions.

Tabula Rasa is a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital software solutions and novel, proprietary medication decision support tools.

*Find out more about DC Advisory >

 

Date
Sectors
  • Healthcare
Deal type
  • M&A Advisory
Deal locations
United States
Deal team
UN SDG Activity
  • GOAL 3: Good Health and Well-being
Actions
Back to News, Deals & Insights

Disclaimer

For more information, please see our transaction disclaimer

Contact form

Thank you!

Your message has been received by DC Advisory so you'll hear back from us soon.

We collect your personal data if you sign up to receive news or get in touch with us. This is collected by third-party firms on our behalf. We have three separate lists:

  1. DealCloud - which we use as our CRM. DealCloud privacy statement is available here: https://www.intapp.com/privacy/
  2. SalesForce - which we use as our CRM. SalesForce privacy statement is available here: https://www.salesforce.com/uk/company/privacy/
  3. Spotler - which we use to send email marketing campaigns. Spotler privacy statement is available here: https://spotler.co.uk/privacy-policy/

Application form

Application documents*
(Maximum file size of 10 MB. File types accepted: pdf or doc)
* Compulsory fields

Thank you!

Your message has been received by DC Advisory so you'll hear back from us soon.

Back to top